Literature DB >> 35271696

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination.

Adrien Picod1,2, Jean-Michel Rebibou1,3, Antoine Dossier1,4, Bérengère Cador1,5, David Ribes6, Claire Vasco-Moynet7, Caroline Stephan8, Mathieu Bellal9, Alain Wynckel1,10, Pascale Poullin1,11, Edwige Péju12, Laure Ricard1,13, Jean-Emmanuel Kahn14, Raïda Bouzid1, Ygal Benhamou1,15, Bérangère Joly1,16,17, Agnès Veyradier1,16,17, Paul Coppo1,13,18.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35271696      PMCID： PMC8916825          DOI： 10.1182/blood.2021015149

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  13 in total

Review 1.  Thrombotic thrombocytopenic purpura.

Authors:  Bérangère S Joly; Paul Coppo; Agnès Veyradier
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

2.  Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.

Authors:  Sue Pavord; Marie Scully; Beverley J Hunt; William Lester; Catherine Bagot; Brian Craven; Alex Rampotas; Gareth Ambler; Mike Makris
Journal:  N Engl J Med       Date:  2021-08-11       Impact factor: 91.245

3.  Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience.

Authors:  Paul Coppo; Michael Schwarzinger; Marc Buffet; Alain Wynckel; Karine Clabault; Claire Presne; Pascale Poullin; Sandrine Malot; Philippe Vanhille; Elie Azoulay; Lionel Galicier; Virginie Lemiale; Jean-Paul Mira; Christophe Ridel; Eric Rondeau; Jacques Pourrat; Stéphane Girault; Dominique Bordessoule; Samir Saheb; Michel Ramakers; Mohamed Hamidou; Jean-Paul Vernant; Bertrand Guidet; Martine Wolf; Agnès Veyradier
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

4.  Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.

Authors:  Eric Mariotte; Elie Azoulay; Lionel Galicier; Eric Rondeau; Fouzia Zouiti; Pierre Boisseau; Pascale Poullin; Emmanuel de Maistre; François Provôt; Yahsou Delmas; Pierre Perez; Ygal Benhamou; Alain Stepanian; Paul Coppo; Agnès Veyradier
Journal:  Lancet Haematol       Date:  2016-04-16       Impact factor: 18.959

5.  Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.

Authors:  Marie Scully; Deepak Singh; Robert Lown; Anthony Poles; Tom Solomon; Marcel Levi; David Goldblatt; Pavel Kotoucek; William Thomas; William Lester
Journal:  N Engl J Med       Date:  2021-04-16       Impact factor: 91.245

6.  First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpura.

Authors:  Kaitlyn C Dykes; Craig M Kessler
Journal:  Blood Coagul Fibrinolysis       Date:  2022-01-01       Impact factor: 1.276

7.  Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study.

Authors:  Matthias B Moor; Franziska Suter-Riniker; Michael P Horn; Daniel Aeberli; Jennifer Amsler; Burkhard Möller; Linet M Njue; Cesare Medri; Anne Angelillo-Scherrer; Luca Borradori; Susanne Radonjic-Hoesli; S Morteza Seyed Jafari; Andrew Chan; Robert Hoepner; Vera Ulrike Bacher; Laila-Yasmin Mani; Joseena Mariam Iype; Cédric Hirzel; Britta Maurer; Daniel Sidler
Journal:  Lancet Rheumatol       Date:  2021-09-07

8.  Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.

Authors:  Andreas Greinacher; Kathleen Selleng; Raghavendra Palankar; Jan Wesche; Stefan Handtke; Martina Wolff; Konstanze Aurich; Michael Lalk; Karen Methling; Uwe Völker; Christian Hentschker; Stephan Michalik; Leif Steil; Alexander Reder; Linda Schönborn; Martin Beer; Kati Franzke; Andreas Büttner; Boris Fehse; Evi X Stavrou; Chandini Rangaswamy; Reiner K Mailer; Hanna Englert; Maike Frye; Thomas Thiele; Stefan Kochanek; Lea Krutzke; Florian Siegerist; Nicole Endlich; Theodore E Warkentin; Thomas Renné
Journal:  Blood       Date:  2021-12-02       Impact factor: 25.476

9.  Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.

Authors:  Hannah Maayan; Ilya Kirgner; Odit Gutwein; Katrin Herzog-Tzarfati; Naomi Rahimi-Levene; Maya Koren-Michowitz; Dorit Blickstein
Journal:  J Thromb Haemost       Date:  2021-07-07       Impact factor: 16.036

10.  Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources.

Authors:  Andreas Greinacher; Florian Langer; Mike Makris; Menaka Pai; Sue Pavord; Huyen Tran; Theodore E Warkentin
Journal:  J Thromb Haemost       Date:  2021-11-10       Impact factor: 5.824
View more
  1 in total

1.  Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.

Authors:  Imen Ben Saida; Iyed Maatouk; Radhouane Toumi; Emna Bouslama; Hajer Ben Ismail; Chaker Ben Salem; Mohamed Boussarsar
Journal:  Vaccines (Basel)       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.